The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
pierre fabre medicament | 285 |
pf medicament | 19 |
merck & company | 4 |
roche | 2 |
pierre fabre mecament | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
novel antibodies inhibiting c-met dimerization, and uses thereof | 102 | 2007 |
anti-cmet antibody | 81 | 2008 |
derivatives of dolastatin 10 and auristatins | 68 | 2013 |
anti cxcr4 antibodies and their use for the treatment of cancer | 41 | 2008 |
aminocyclobutane derivatives, method for preparing same and the use thereof as drugs | 40 | 2012 |
derivatives of azaindazole or diazaindazole type as medicament | 40 | 2011 |
antigen binding protein and its use as addressing product for the treatment of cancer | 40 | 2011 |
dha esters and use thereof in the treatment and the prevention of cardiovascular diseases | 39 | 2006 |
anti cxcr4 antibodies for the treatment of hiv | 39 | 2009 |
humanized anti cxcr4 antibodies for the treatment of cancer | 38 | 2010 |